Glucomannan minimizes the postprandial insulin surge: A potential adjuvant for hepatothermic therapy

Medical Hypotheses

Volumn 58, Issue 6, 2002, Pages 487-490

  McCarty, Mark F ^a  

^a Pantox Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANNAN; PROPOL;

AGING; CANCER RISK; CARBOHYDRATE ABSORPTION; CONSTIPATION; DIABETES CONTROL; HEPATOTHERMIC THERAPY; HUMAN; INSULIN RESPONSE; LIPID METABOLISM; LIVER METABOLISM; METABOLIC REGULATION; OBESITY; PRIORITY JOURNAL; REVIEW; SATIETY; SIDE EFFECT;

RODENTIA;

EID: 0036619711     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2001.1457     Document Type: Article

References (45)

1. Dietary fibre, complex carbohydrate and coronary artery disease
2. The role of viscous soluble fiber in the metabolic control of diabetes: A review with special emphasis on cereals rich in beta-glucan
3. Dietary fibre, lente carbohydrates and the insulin-resistant diseases
4. Effect of konjac fibre (glucomannan) on glucose and lipids
5. Glucomannan prevents postprandial hypoglycaemia in patients with previous gastric surgery
6. Physicochemical comparison of the dietary fibers glucomannan, galactomannan, carboxymethylcellulose, pectin, and wheat bran
7. Effect of dietary fiber, glucomannan, on absorption of sulfonylurea in man
8. Effect of dietary fibre on postprandial thermogenesis
9. Dietary fiber in the dietetic therapy of diabetes mellitus. Experimental data with purified glucomannans
10. Action of glucomannans on complaints in patients affected with chronic constipation: A multicentric clinical evaluation
11. Use of glucomannan dietary fiber in changes in intestinal habit
12. Effect of the dietary fiber glucomannan on chronic constipation in neurologically impaired children
13. Degradation of konjac glucomannan by enzymes in human feces and formation of short-chain fatty acids by intestinal anaerobic bacteria
14. Treatment of diabetes with glucomannan (konjac mannan)
15. Effect of konjac food on blood glucose level in patients with diabetes
16. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes: A randomized controlled metabolic trial
17. Second-meal effect: Low-glycemic-index foods eaten at dinner improve subsequent breakfast glycemic response
18. Double-blind evaluation of glucomannan versus placebo in postinfarcted patients after cardiac rehabilitation
19. Chronic use of glucomannan in the dietary treatment of severe obesity
20. The use of highly purified glucomannan-based fibers in childhood obesity
21. Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients
22. Effect of glucomannan on obese patients: A clinical study
23. Gastric volume rather than nutrient content inhibits food intake
24. High glycemic index foods, overeating, and obesity
25. The role of the ileum in food intake regulation
26. Disproportionate ileal digestion on canine food consumption: A possible model for satiety in pancreatic insufficiency
27. Beneficial effects of viscous dietary fiber from konjac-mannan in subjects with the insulin resistance syndrome: Results of a controlled metabolic trial
28. Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men
29. Cholesterol-lowering effects of dietary fiber: A meta-analysis
30. Regulation of hepatic 7 alpha-hydroxylase expression by dietary psyllium in the hamster
31. Cholesterol 7 alpha-hydroxylase activity is increased by dietary modification with psyllium hydrocolloid, pectin, cholesterol and cholestyramine in rats
32. Effect of lactulose and fiber-rich diets on bile in relation to gallstone disease: An update
33. Regulation of cholesterol 7 alpha-hydroxylase by different effectors
34. Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription
35. Transcriptional regulation of the human cholesterol 7 alpha-hydroxylase gene (CYP7A) in HepG2 cells
36. Insulin exposure controls the rate of mammalian aging
37. Up-regulation of IGF binding protein-1 as an anticarcinogenic strategy: Relevance to caloric restriction, exercise, and insulin sensitivity
38. Dietary glycemic index may influence cancer risk by modulating IGF-I activity: A hypothesis
39. Effect of konjac mannan on spontaneous liver tumorigenesis and fecal flora in C3H/He male mice
40. Effect of konjac mannan on 1,2-dimethylhydrazine-induced intestinal carcinogenesis in Fischer 344 rats
41. Inhibitory effect of refined Amorphophallus konjac on MNNG-induced lung cancers in mice
42. Long-term animal feeding trial of the refined konjac meal. II. Effects of the refined konjac meal on the aging of the brain, liver, and cardiovascular tissue cells in rats
43. Pyruvate and hydroxycitrate/carnitine may synergize to promote reverse electron transport in hepatocyte mitochondria, effectively 'uncoupling' the oxidation of fatty acids
44. Hepatothermic therapy of obesity: Rationale and an inventory of resources
45. Incorporation of beta cell redifferentiation therapy into a lipoprivic strategy for reversing type 2 diabetes